Search

Search

Log in or registerMenuClose

Search

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

Legal 500 Trust Centre
Contact Us

Market Intelligence
Search

1,038 results found

Use advanced search filters to refine your search

Search

2 filters applied

Advanced search filters

Topics

Search for topics

Countries

Search for countries

Contributor

Search to show contributors

Start typing to add contributors

Content type

Any
Article
Podcast
Video

Sort by

Article
Ensuring Integrity In Food Testing: FSSAI's Enforcement Of Statutory Obligations Through InFoLNet Integration And NABL Accreditation Compliance
The integrity of food safety governance in India fundamentally depends upon the reliability, transparency, and accountability of the laboratory infrastructure entrusted with the critical function of food testing and analysis.
IndiaFood, Drugs, Healthcare, Life Sciences
IndiaLaw LLP
Article
Food & Pharma Flash - March 2014
Last year, Pharma sector witnessed major positive developments on the regulatory front.
IndiaFood, Drugs, Healthcare, Life Sciences
PSA

From Periodic To Perpetual: Legal Implications Of India's New Food Safety Licensing Regime

The Food Safety and Standards Authority of India (FSSAI) has introduced significant amendments to the Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations through its 2026 Amendment...

IndiaFood, Drugs, Healthcare, Life Sciences

Mandatory Registration Of Foreign Food Manufacturing Facilities: Origins And Detailed Instructions From FSSAI And CBIC

The Ministry of Finance, in collaboration with the Food Safety and Standards Authority of India (FSSAI), has laid out comprehensive guidelines to implement the mandatory registration of

IndiaFood, Drugs, Healthcare, Life Sciences

New Drugs And Clinical Trials (Amendment) Rules, 2024

The Ministry of Health and Family Welfare has on September 19, 2024, announced significant amendments to the New Drugs and Clinical Trials Rules, 2019 ("NDCT Rules, 2019").

IndiaFood, Drugs, Healthcare, Life Sciences

JSA Advocates & Solicitors

Requirement Of Bio-Equivalence Studies For Generic Drugs – A Step In The Right Direction

Access to affordable and safe medicines is the cornerstone of a vibrant public health framework.

IndiaFood, Drugs, Healthcare, Life Sciences

Supreme Court Asks Drug Technical Advisory Board To Decide Fate Of 349 Banned Fixed Drug Combination (FDCs) Medicines

The Supreme Court, in its judgment on December 15, 2017, on the matter of fixed drug combinations, has asked the Centre to make arrangement for experts to examine 349 fixed dose combination medicines ...

IndiaFood, Drugs, Healthcare, Life Sciences

S&A Law Offices

The Drugs And Cosmetics (11th Amendment) Rules, 2019, Offers Effective Implementation Of Permanency Of Licenses

The Drugs and Cosmetics (10th Amendment) Rules, 2017 dated October 27, 2017, announced that the manufacturing and sale licenses of drugs once issued shall remain valid forever ...

IndiaFood, Drugs, Healthcare, Life Sciences

S&A Law Offices

CFOs Expectations Of Union Budget 2023

As Union Budget 2023-24, the last full-year budget for the current government, will be closely watched by India Inc. as it sets the tone for the economic policies of the government.

IndiaGovernment, Public Sector

Nexdigm Private Limited

Are Known Substances Really A Patentable Subject Matter In Light Of Indian Patents Act, 1970

It is well stated in the Indian Patents Act, 1970 that grant of Product patent in India mainly in the areas of Pharmaceutical industry holds a relevance importance.

IndiaIntellectual Property

S&A Law Offices

Bolar Provision Remains Standing After Bayer Challenge

The Delhi High Court recently adjudicated on the issue of whether generic companies can export patented products for experimental purpose, in an expansive interpretation of Section 107A of the ...

IndiaIntellectual Property

Diligence & Proactiveness - Important Factors For Grant Of Injunction

The Delhi High Court recently decided an interim injunction application in a civil suit between Ajanta Pharma Ltd.

IndiaIntellectual Property

Managing Intellectual Property Rights In Indian Pharmaceutical Companies -Innovative Techniques For In‑House Legal Teams

The pharmaceutical sector in India is a high‑rewarding sector where protection and management of intellectual property rights ("IPR") is imperative to maintain novelty, profitability and competitiveness in the market...

IndiaIntellectual Property

Maheshwari & Co. Advocates & Legal Consultants

Patent Refused Without Addressing All Objections: Delhi High Court Orders Reconsideration

The subject invention disclosed a medicine/drug composition/pharmaceutical formulation useful for the treatment of a neurodegenerative disease and capable of reducing adverse side effects...

IndiaIntellectual Property

Solving For The Looming Pandemic Patent Crisis In India

The COVID-19 pandemic has posed some unusual problems for states and markets all over the world. While medical science and pharmaceutical professionals continue their search for the best drug...

IndiaIntellectual Property

TRIPS IP Waiver: One Country's Meat Is A Pharmaceutical Corporation's Poison

The Trade-Related Aspects of Intellectual Property Rights Council has proposed a temporary Intellectual Property waiver for vaccines and other drugs essential for treatment of COVID.

IndiaIntellectual Property

InvnTree Intellectual Property Services Pvt. Ltd.

Voluntary Licensing Agreements For Remdesivir

Gliead is rapidly working to fight with this outbreak of novel COVID-19. Remdesivir is a potential drug for the treatment for COVID-19

IndiaIntellectual Property

Khurana & Khurana, Advocates and IP Attorneys

Treat For Tennis Fans – Sharapova Ban Reduced

The Court of Arbitration for Sports has finally given its arbitral award in the dispute between Ms. Maria Sharapova and the International Tennis Federation wherein Sharapova had challenged the 2 year ban.

IndiaMedia, Telecoms, IT, Entertainment

Non-Patent Exclusivity In US & EU

Non-patent exclusivity or Regulatory exclusivity is the core profit driver of the pharma industry.

GlobalFood, Drugs, Healthcare, Life Sciences

Khurana & Khurana, Advocates and IP Attorneys

CCI Exonerates RDCA Of Anti-Competitive Conduct In Pharmaceutical Market- Disagrees Again With Findings Of The DG

After the investigation DG found that the RDCA was levying and collecting PIS charges in Mumbai.

IndiaAntitrust/Competition Law

Vaish Associates Advocates

Showing 521–540 of 1038 results

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics